Chief Medical Officer (7) · Harpoon Therapeutics, Inc. (HARP)

Luke Walker

FY2022 is the first fiscal year CompBrief holds for Luke Walker as a named executive officer of Harpoon Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$668,964

Salary $125,000Stock awards $0Bonus $250,000

5th of 5 named executive officers at Harpoon Therapeutics by FY2022 total.

5 named officers on file for Harpoon Therapeutics, FY2022

Luke Walker’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Harpoon Therapeutics’s whole pay program stands against its peers

  • Harpoon Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HARP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get Luke Walker’s full pay file as a PDF — free

More than this page: up to 10 years of Luke’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Luke Walker compensation by year

Harpoon Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Harpoon Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$125,000
Bonus$250,000
Stock awards$0
Option awards$244,530
Non-equity incentive$48,767
Pension and deferred compensation$0
All other$667
Total$668,964

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Harpoon Therapeutics, Inc. DEF 14A filed April 27, 2023, accession 0001193125-23-122195, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Harpoon Therapeutics, Inc. filed document, accession 0001193125-23-122195. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option305,000—$1.08

Per the Outstanding Equity Awards at Fiscal Year-End table in Harpoon Therapeutics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Harpoon Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Holger WescheFormer Chief Science Officer (10)$1,432,904
Julie EastlandPresident, Chief Executive Officer and Director$1,160,774
Natalie SacksFormer Chief Medical Officer (9)$757,280
Georgia ErbezFormer Chief Financial Officer (8)$727,847
Luke Walker · this pageChief Medical Officer (7)$668,964

The full Harpoon Therapeutics compensation record

free company brief

This page is one person within Harpoon Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Harpoon Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Luke Walker's compensation dossier · One-time report. No refunds.